June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Humphrey Visual Field 10-2 performance in eyes with multifocal versus monofocal intraocular lens implants
Author Affiliations & Notes
  • Garrick Chak
    Ophthalmology, Gavin Herbert Eye Inst, UC Irvine, Irvine, CA
  • Marjan Farid
    Ophthalmology, Gavin Herbert Eye Inst, UC Irvine, Irvine, CA
  • Sumit Garg
    Ophthalmology, Gavin Herbert Eye Inst, UC Irvine, Irvine, CA
  • Roger Steinert
    Ophthalmology, Gavin Herbert Eye Inst, UC Irvine, Irvine, CA
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3011. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Garrick Chak, Marjan Farid, Sumit Garg, Roger Steinert; Humphrey Visual Field 10-2 performance in eyes with multifocal versus monofocal intraocular lens implants. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3011.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate differences in Humphrey Visual Field (HVF) 10-2 testing in healthy eyes with multifocal versus monofocal intraocular lens (IOL) implants.

Methods: A prospective, age matched, comparative analysis of HVF 10-2 performance on 58 eyes of 29 patients was done. All patients had healthy eyes with bilateral multifocal (n=16) or monofocal (n=13) IOL implants. Mean deviation and pattern standard deviation numerical values were evaluated and compared between groups.

Results: The average mean deviation was -2.52 dB (SD 2.48) for the multifocal IOL group and -1.28 dB (SD 1.74) for the monofocal IOL group (p = 0.03). The average pattern standard deviation was 1.45 dB (SD 0.95) and 1.59 dB (SD 0.88) for the multifocal and monofocal IOL groups, respectively (p = 0.58).

Conclusions: Multifocal IOL implants cause significant non-specific reduction in mean deviation values on HVF 10-2 testing and may be inadvisable in patients where central visual field reduction may not be tolerated, such as macular degeneration and glaucoma. Furthermore, multifocal IOL implantation may be inadvisable in patients on systemic chloroquine or hydroxychloquine as it can result in confounding visual field results on routine toxicity screening.

Keywords: 758 visual fields • 445 cataract • 630 optical properties  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×